Neurotherapeutics Pharma - Top 5 Biotech VC Deals, H1 2010
Company: Neurotherapeutics Pharma
Based: Chicago, IL
Amount: $43M
Investors: Fidelity Biosciences, MPM Capital, SR One, Pfizer, Novo Ventures, Thomas McNerney & Partners
Scoop: Neurotherapeutics' landed $43 million to support its lead central nervous system drug NPT-2014 through multiple proof-of-concept studies. The company hopes that it has a platform that can deliver drugs for a broad range of diseases such as epilepsy, neuropathic and acute pain.
Related Articles:
Big Pharma firms back $43M round for NeuroTherapeutics
Is the market for biotech start-ups coming back to life?
Live from BIO: What do biotech VCs want?
SHARE
WITH: